Etoposide Injection
Sponsors
Taizhou Hospital, University of Maryland, Baltimore, Nanjing Leads Biolabs Co.,Ltd, BeBetter Med Inc, Beijing Chest Hospital, Capital Medical University
Conditions
Advanced Extrapulmonary Neuroendocrine CarcinomaAdvanced Neuroendocrine CarcinomaExtensive-stage Small-cell Lung CancerLimited-stage Small-cell Lung CancerMalignant Solid TumorsNatural Killer/T-cell LymphomaRelapsed/Refractory Diffuse Large B-Cell LymphomaSmall Cell Lung Cancer
Phase 1
Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC
SuspendedNCT05403723
Start: 2026-06-30End: 2027-08-01Target: 50Updated: 2026-02-19
A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma
RecruitingNCT06157827
Start: 2023-12-08End: 2027-03-28Target: 178Updated: 2026-03-12
Study of BEBT-908 Combined With Drugs in the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT06164327
Start: 2023-12-01End: 2025-11-05Target: 75Updated: 2023-12-11
A Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer
Active, not recruitingNCT07009457
Start: 2025-06-16End: 2028-09-01Updated: 2026-06-30
Phase 2
First-line Chemotherapy Followed by Toripalimab Combined With Anlotinib for Maintenance in ES-SCLC
NCT04363255
Start: 2020-05-01End: 2023-03-31Target: 20Updated: 2020-04-28
PD-L1/PD-1 Inhibitors Plus Chemotherapy Versus Chemotherapy Alone for the Neoadjuvant Treatment of Limited-stage SCLC
Not yet recruitingNCT06375109
Start: 2024-04-16End: 2029-04-15Target: 60Updated: 2024-04-19
A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer
Not yet recruitingNCT06786312
Start: 2025-01-25End: 2028-09-25Target: 34Updated: 2025-01-22
A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors
RecruitingNCT07268040
Start: 2025-12-23End: 2028-12-31Target: 400Updated: 2026-01-12
SKB500 Combinations in Patients With Small Cell Lung Cancer
RecruitingNCT07296809
Start: 2026-01-30End: 2029-12-31Target: 80Updated: 2026-05-08
GELAD-Based Response-Adapted Treatment for Early-Stage Extranodal NK/T-Cell Lymphoma
Not yet recruitingNCT07768943
Start: 2026-09-01End: 2036-06-30Target: 620Updated: 2026-08-17
Phase 3
Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
RecruitingNCT06792253
Start: 2025-01-06End: 2029-06-30Target: 416Updated: 2026-08-19
A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC
Not yet recruitingNCT07720193
Start: 2026-08-22End: 2030-12-22Target: 280Updated: 2026-09-01